EDITORIAL
Published on 04 Jan 2023
Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
doi 10.3389/fnagi.2022.1116635
- 1,262 views
- 3 citations
- Frontiers in Aging Neuroscience
- Cellular and Molecular Mechanisms of Brain-aging
- Research Topics
- Targeting the Endocannabinoidome in Neurodegenerative Disorders
Targeting the Endocannabinoidome in Neurodegenerative Disorders
4,431
Total downloads
16k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 16 Nov 2022
Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease
doi 10.3389/fnagi.2022.1004002
- 2,947 views
- 10 citations
ORIGINAL RESEARCH
Published on 14 Oct 2022
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity
doi 10.3389/fnagi.2022.926634
- 2,341 views
- 8 citations
REVIEW
Published on 04 Oct 2022
Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
doi 10.3389/fnagi.2022.949361
- 3,453 views
- 4 citations
BRIEF RESEARCH REPORT
Published on 30 Sep 2022
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
doi 10.3389/fnagi.2022.1018610
- 2,115 views
- 11 citations
